You haven't searched anything yet.
Foghorn Therapeutics, a prominent clinical-stage biotechnology company, is seeking a highly motivated and skilled candidate to join their team as a 2024 COOP CMC Formulation Development. The successful candidate will have the opportunity to work in a dynamic and fast-paced environment as part of a team that is revolutionizing the field of chromatin regulation. Foghorn Therapeutics aims to develop a new class of medicines that modulate the chromatin regulatory system, thus orchestrating the genes our cells express, including when, where, and in what order. With over 10 programs in various stages of development, the company is aggressively pursuing treatments for a wide range of cancers and other diseases. A commitment to making a real difference in the lives of fellow human beings underpins the company's mission.
ResponsibilitiesFoghorn Therapeutics is pleased to provide you and your family with a comprehensive suite of benefits, including:
Foghorn Therapeutics is a smoke-free, alcohol-free and drug-free work environment.
Foghorn is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Foghorn Therapeutics will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Temporary
Pharmaceutical
$90k-113k (estimate)
05/18/2024
07/10/2024
foghorntx.com
CAMBRIDGE, MA
100 - 200
2016
ADRIAN GOTTSCHALK
<$5M
Pharmaceutical